PHARMA EVIDENCE ApS: Financial statements 2018
CVR: 34586519
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,116,888 and a net result of DKK 123,447 compared with DKK 279,719 the year before. That is an increase of 78.6% compared with the year before. Equity in the 2018 report amounted to DKK 429,013. The solvency ratio was 58.4%.
- Gross Profit
- DKK 1,116,888
- Profit/Loss
- DKK 123,447
- Equity
- DKK 429,013
- Total Assets
- DKK 734,367
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.1 mio. | 123 t. | 429 t. | - |
| 2017 | - | 625 t. | 280 t. | 306 t. | 1 |
| 2016 | - | -28 t. | -48 t. | 26 t. | - |
| 2015 | - | 255 t. | -154 t. | 73 t. | - |
| 2014 | - | 1.3 mio. | -237 t. | 227 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of September 17, 2018, HB World Holding ApS is registered as an owner of PHARMA EVIDENCE ApS with an ownership share of 100%.
PHARMA EVIDENCE ApS has published its annual report for 2017. Gross profit came to DKK 625,347, and the net result was DKK 279,719.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.